- Home
- TIL vs AMRN Comparison
TIL vs AMRN Comparison
Compare TIL & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIL
- AMRN
- Stock Information
- Founded
- TIL 2018
- AMRN 1989
- Country
- TIL United States
- AMRN Ireland
- Employees
- TIL N/A
- AMRN N/A
- Industry
- TIL Biotechnology: Pharmaceutical Preparations
- AMRN Biotechnology: Pharmaceutical Preparations
- Sector
- TIL Health Care
- AMRN Health Care
- Exchange
- TIL Nasdaq
- AMRN Nasdaq
- Market Cap
- TIL 230.1M
- AMRN 216.0M
- IPO Year
- TIL 2021
- AMRN 1993
- Fundamental
- Price
- TIL $27.56
- AMRN $12.64
- Analyst Decision
- TIL Buy
- AMRN Strong Sell
- Analyst Count
- TIL 5
- AMRN 1
- Target Price
- TIL $119.00
- AMRN $7.00
- AVG Volume (30 Days)
- TIL 503.4K
- AMRN 95.3K
- Earning Date
- TIL 08-12-2025
- AMRN 07-30-2025
- Dividend Yield
- TIL N/A
- AMRN N/A
- EPS Growth
- TIL N/A
- AMRN N/A
- EPS
- TIL N/A
- AMRN N/A
- Revenue
- TIL N/A
- AMRN $214,112,000.00
- Revenue This Year
- TIL N/A
- AMRN N/A
- Revenue Next Year
- TIL N/A
- AMRN $7.88
- P/E Ratio
- TIL N/A
- AMRN N/A
- Revenue Growth
- TIL N/A
- AMRN N/A
- 52 Week Low
- TIL $9.62
- AMRN $7.08
- 52 Week High
- TIL $92.00
- AMRN $16.37
- Technical
- Relative Strength Index (RSI)
- TIL 51.84
- AMRN 63.66
- Support Level
- TIL $27.01
- AMRN $12.80
- Resistance Level
- TIL $42.79
- AMRN $14.01
- Average True Range (ATR)
- TIL 5.01
- AMRN 0.80
- MACD
- TIL -1.00
- AMRN 0.04
- Stochastic Oscillator
- TIL 9.82
- AMRN 54.09
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.